Home › Topics › Antitubercular therapy
Pharmacology & therapeutics
Antitubercular therapy
Also called ATT, anti-tubercular treatment, DOTS, rifampicin, isoniazid
JIMSA has published 18 articles on antitubercular therapy between 2005 and 2024: 5 original articles, 4 editorials, 2 case reports and 1 symposium paper. Every article is free to read.
Articles about antitubercular therapy
- Factors Affecting Treatment Outcomes in Rifampicin Sensitive Pulmonary Tuberculosis
- Smoking/Chest X-Ray Severity Effect on Sputum Culture Conversion in Multi Drug Resistant Tuberculosis Patient
- Pseudochylothorax as a Primary Manifestation of Rheumatoid Arthritis: A Case Report
- Spectrum of Tubercular Diseases among HIV Positive Patients and Response to Antitubercular Therapy
- Comparison of Outcomes of Anti-Tubercular Chemotherapy Prescribed for 9 months and 12 months in POTT’s Spine
- Assessment of Knowledge, Attitude and Perception regarding Tuberculosis amongst Medical Students of Government Medical College of North India
- Rifampicin Induced Thrombocytopenia:A Case Report
- XDR Tuberculosis: Danger Ahead
- Multidrug-Resistant Tuberculosis (MDR-TB): Epidemiology, Mechanisms of Drug Resistance
- UPDATE IN THERAPY : Drug Induced Liver Injury
- Multidrug Resistant Tuberculosis (MDR-TB) : DDS Kulpati
- Management of Multidrug Resistant Tuberculosis (MDR-TB)
Also discussed in
- A rather quirky method of memorising pharmacodynamics of important anti-TB drugs
- Drug Profile
- Occurrence and Antimicrobial Susceptibility Pattern of Community and Hospital Associated Methicillin Resistant Staphylococcus aureus Strains in Sikkim
- An Unusual Etiology of PUO
- Role Of Diagnostic Laparoscopy In Patients Of Chronic Abdominal Pain
- Diagnosis of MDR Tuberculosis